Abstract-Myocytes overlying a zone of infarction form the primary substrate for serious reentrant ventricular arrhythmias.
T he antiarrhythmic effect of lidocaine in cardiac tissue derives from use-dependent suppression of excitability through block of voltage-gated Na ϩ channels. Although detailed electrophysiological studies have evaluated the mechanism of lidocaine action in healthy cardiac tissue, we sought to evaluate cells of the epicardial border zone (EBZ) of the infarcted heart, which have been reported to contribute to the formation of the substrate for serious ventricular arrhythmias. [1] [2] [3] Abnormal electrical properties of fibers of the EBZ of the 5-day infarcted heart result partly from alterations of voltage-gated ion channels. [4] [5] [6] V max values are reduced in fibers of the multicellular EBZ preparation of the 5-day infarcted heart, 3, 4, 7 suggesting that Na ϩ current (I Na ) is reduced in cells that survive in the EBZ of the healing infarcted heart (IZs). Nonetheless, infarct-induced changes in channel number or density should impose no functional change in antiarrhythmic drug action. Conversely, infarct-associated changes in Na ϩ channel gating may profoundly modify the usedependent action of antiarrhythmic agents. In addition to a reduction in V max , a delay in recovery of V max and a shift in the steady-state availability of V max have been described for action potentials of IZs. 4, 7 We have reported that these changes in V max are due to abnormalities in Na ϩ channel gating in myocytes from the EBZ. 6 Evidence from both in vitro and in vivo studies suggests that antiarrhythmic agents affect Na ϩ channels from the EBZ differently than they affect those from normal muscle. For instance, in noninfarcted epicardial fibers, lidocaine superfusion reduced V max and increased action potential duration with little change in refractoriness 8, 9 but depressed conduction and prolonged refractoriness in EBZ fibers in vitro 9, 10 as well as in the intact dog heart after coronary occlusion. 11 Studies by Coromilas et al 12 and others 11, 13, 14 have emphasized the limited efficacy of class I drugs such as lidocaine and flecainide on the ventricular tachycardias occurring in the EBZ 3 to 5 days after infarction. In fact, flecainide increased the likelihood that premature electrical impulses were blocked in the EBZ, suggesting that the proarrhythmic effect of flecainide may be due to an exceptionally prolonged drug-induced delay in conduction in fibers of the EBZ. Similarly, a prominent rate-dependent slowing of conduction observed in EBZ fibers facilitated reentry in the presence of lidocaine. 14 In recent work, we showed that the inactivation gating properties of Na ϩ channels in myocytes derived from the EBZ are modified. 6 I Na from these myocytes inactivates at more hyperpolarized membrane potentials (negative voltage shift in steady-state inactivation) and also exhibits a prominent delay in recovery from inactivation. Recent studies with both site-directed mutations [15] [16] [17] and subsidiary (␤ 1 ) subunit coexpression 18, 19 have shown that interventions that alter Na ϩ channel inactivation gating may profoundly influence the action of Na ϩ channel-blocking antiarrhythmic drugs. It is unclear whether and how these interventions modify lidocaine action. In theory, structural interventions that modify gating may, in turn, alter lidocaine-induced use dependence by changing the effect of the local anesthetic on inactivation gating kinetics. 20, 21 We examined whether Na ϩ channels of IZs of the 5-day infarcted heart exhibit altered functional sensitivity to the antiarrhythmic agent lidocaine. Unexpectedly, both IZs and myocytes from the noninfarcted heart (NZs) exhibited the same use-dependent current reduction with lidocaine exposure, despite marked differences in fastinactivation gating under drug-free conditions.
Materials and Methods

Cell Preparation
Adult mongrel male dogs (12 to 18 kg, 1 to 2 years old) were used in these studies. Myocardial infarction was produced according to the Harris procedure. 22 Under isoflurane anesthesia and sterile conditions, the left anterior descending coronary artery was isolated and completely occluded in 2 stages. Dogs were treated with lidocaine (2 mg/kg IV) if multiple ventricular beats occurred at the time of the surgical procedure. After 5 to 6 days, a cardiectomy was performed with the dogs under sodium pentobarbital (30 mg/kg IV) anesthesia. The infarcted region of the heart was identified on gross examination as a pale white mottled area on the epicardial surface. A scalpel blade was used to quickly remove a thin slice 1 cmϫ2 cmϫ2 to 3 mm of epicardial muscle (EBZ) from this area on the anterior left ventricle adjacent to the left anterior descending coronary artery.
Single Ca 2ϩ -tolerant ventricular myocytes were enzymatically dispersed from the slice of EBZ tissue (IZs) and from slices of epicardial tissue obtained in a similar fashion from the same anatomic region of control noninfarcted hearts (NZs), as previously described by our laboratory. 4, 6 Briefly, the tissue was rinsed twice in a Ca 2ϩ -free solution containing (mmol/L) NaCl 115, KCl 5, sucrose 35, dextrose 10, HEPES 10, and taurine 4, pH 6.95, to remove blood. Then it was triturated in 20 mL of enzyme-containing solution (collagenase B, 0.38 mg/mL, Worthington Biochemical Corp; protease, 0.25 mg/mL, Sigma; 36°C to 37°C) for 30 minutes, after which the solution was decanted and discarded. For a second trituration, the solution contained only collagenase and was discarded after 30 minutes. The next 6 to 7 triturations were each performed for 15 minutes. Each time, the solution was centrifuged at 500 rpm for 3 minutes to collect the supernatant and the dispersed myocytes. Resuspension solution was changed every 30 minutes for solutions containing increasing concentrations of Ca 2ϩ (50 to 500 mol/L). With this procedure, the living NZ yield was Ϸ30% to 40%. For NZs, only rod-shaped cells with staircase ends, clear cross striations, and surface membranes free from blebs were used for study. IZs chosen for study, however, had a ruffled appearance, were less rodlike appearing, and had somewhat irregular cross striations and small dark droplets on the membrane. Our recent studies show that these morphological features indicate the IZs that exhibit abnormal transmembrane action potentials similar to those of the multicellular preparation of the EBZ.
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Experimental Conditions
For study, an aliquot of cells was transferred onto a polylysinecoated glass coverslip placed at the bottom of a 0.5-mL tissue chamber, which had been mounted on the stage of a Nikon inverted microscope (Nikon Diaphot). Myocytes were continuously superfused (2 to 3 mL/min) with normal Tyrode's solution containing (mmol/L) NaCl 137, NaHCO 3 24 and preliminary experiments showed that the Mn 2ϩ effect on I Na in IZs was similar to its effect in NZs. 6 With this combination of external and internal solutions, I Na would be of manageable size and isolated from other possible contaminating currents.
Voltage-Clamp and Recording Techniques
Whole-cell I Na s were recorded using the whole-cell patch-clamp technique. Voltage-clamp experiments were performed with an Axopatch 200A clamp amplifier (head stage, CV 201A; gain, ␤ϭ1; Axon Instruments). Clamp protocols were generated with a 16-bit digital/analog converter (Digidata 1200, Axon Instruments) controlled by PCLAMP software and a Gateway 2000 computer. The currents were filtered at 10 kHz, digitized at the sampling interval 0.1 ms for whole-cell currents and 0.02 ms for capacitative transients, and stored on the computer for later analysis. The membrane capacity (in pF) of each cell was measured in the Cs ϩ -rich solution by integrating the area under a capacitative transient induced by a 10-mV hyperpolarizing clamp step (from Ϫ80 to Ϫ90 mV) and dividing this area by the voltage step. Current amplitude data of each cell was then normalized to its cell capacitance (current density [pA/pF]). Averaged cell capacitances were 130Ϯ4.5 pF in NZs (nϭ50) and 171Ϯ8.3 pF in IZs (nϭ38) (PϽ0.05). The average time constant of decay of the capacitive transient was 0.15Ϯ0.01 ms in NZs and 0.16Ϯ0.01 ms in IZs (PϾ0.05). Therefore, the residual series resistance for each cell was calculated to be 1.17Ϯ0.04 M⍀ in NZs and 1.0Ϯ0.04 M⍀ in IZs. Thus, average steady-state voltage error resulting from series resistance was 2.1Ϯ0.11 mV for NZs and 0.9Ϯ0.08 mV for IZs.
For consideration of the voltage control, we lowered the extracellular Na ϩ concentration to 5 mmol/L, maintained the temperature at 19Ϯ0.5°C, and used patch pipettes only with resistances Ͻ1 M⍀. Furthermore, we did not choose large cells. If experiments demonstrating evidence of inadequate voltage control, eg, a "threshold phenomenon" near the voltage range for Na ϩ channel activation, and/or an inappropriately steep increase in current amplitude in the negative slope region of the current-voltage relationship curve, the data were discarded. Whole-cell I Na was obtained by subtracting the traces elicited with comparable voltage steps containing no current (using prepulse to inactivate the Na ϩ channels) from the raw current traces. In this way, the cell capacitance and linear leakage, if present, were subtracted.
Experimental Protocols
Time-dependent changes of Na ϩ channel kinetics, including a shift of the availability curve (I/I max curve) in the hyperpolarizing direction have been observed. [25] [26] [27] Typically, these changes are known to occur within minutes after membrane rupture. We have previously established the degree of shift of I/I max inactivation curves with time after membrane rupture under our recording conditions. 6 From 20 to 50 minutes after membrane rupture, half-maximal activation voltage (V 0.5 ) values showed a similar rate of shifting, 0.14Ϯ0.037 mV/min in NZs (nϭ7) and 0.11Ϯ0.029 mV/min in IZs (nϭ7) (PϾ0.05). Therefore, peak current data collected between Ϸ20 and 50 minutes after membrane rupture were used. Furthermore, in the analysis of data from individual protocols in the absence and presence of drug, only one concentration of lidocaine was tested in each cell. Superfusion of the lidocaine-containing solution was completed for 10 minutes before data were collected. In this way, the averaged time after membrane rupture at which data were collected was well matched for the 2 cell groups.
To examine the effects of lidocaine on peak current density in cells from the 2 groups, voltage steps (50-ms duration) from a holding potential (V H ) of Ϫ100 mV were given stepwise from Ϫ70 to ϩ5 mV (5-s intervals). Peak currents at various test voltages were plotted to obtain the current-voltage relationship curve. The maximal peak current was then divided to cell capacitance to obtain a peak current density (pA/pF) for each cell. The effect of lidocaine on the "steady-state" availability curve (I/I max ) was determined by using a 1000-ms conditioning pulse to various potentials as described before. 6 To determine the effect of lidocaine on time-dependent loss of availability, subthreshold prepulses to Ϫ60 mV of variable duration were applied as previously described. 6 The normalized currents were plotted as a function of the prepulse duration, and a biexponential function was fitted to the data as before. 6, 28, 29 The time course of recovery of I Na availability was assessed using the double-pulse method as described previously. 6 A biexponential function 6, 28, 30, 31 was fitted to the normalized values. With or without lidocaine treatment, many cells (especially IZs) exhibited an additional kinetic component consisting of a delay at shortest interpulse interval (IpI) during the period of recovery from inactivation. Rather than incorporate both a time constant and amplitude for a small third component (high uncertainty), the initial delay in recovery (d) was incorporated into the 2-exponential equation as follows: Tonic block was determined by comparing I Na from the first beat of the pace protocol with and without lidocaine. I Na was induced from different V H levels (Ϫ90, Ϫ100, and Ϫ110 mV ) to Ϫ25 mV for 40 ms. The tonic block showed a dose and V H dependence in both cell types. Block was greater in IZs than in NZs at all V H levels and reached significance with 120 mol/L lidocaine at V H of Ϫ90 and Ϫ100 mV. The greatest amount of tonic block occurred at V H of Ϫ90 mV in both cell types, with 120 mol/L lidocaine causing a 70% decrease in I Na in IZs and a 50% decrease in NZs. The time between membrane rupture and the beginning of data collection was 24.9Ϯ0.9 minutes for NZs and 27.1Ϯ1.1 minutes for IZs (PϭNS Tonic and use-dependent block were determined using repeated pulse trains. In each train, 20 test pulses to Ϫ25 mV were given at rates of 1, 2, and 3 Hz from V H at Ϫ90, Ϫ100, and Ϫ110 mV with at least a 10-s interval between each train. The reduction of I Na at the first pulse after lidocaine was defined as tonic block. The usedependent block was determined by reduction of I Na at the end of the 20th pulse, where the reduction of I Na reached steady state. The data were compared between groups.
Lidocaine hydrochloride (LC Laboratories) was dissolved in water to make a stock solution (2 mmol/L) for use in the external solution.
Statistics
All values are represented as meanϮSEM. A value of PϽ0.05 was considered statistically significant. For 2-sample comparison, an unpaired t test was used to compare a single mean value between the 2 independent cell groups. A paired t test was used to compare the mean values obtained from the same cell group before and after drug intervention. For multiple comparisons, an ANOVA was used, followed by an F test to determine that the sample mean values between groups were significantly different from each other. If so, a modified t test with the Bonferroni correction was used (Sigmastat, Jandel Scientific).
Results
Tonic Block of I Na in NZ and IZ Cells
To examine whether IZs and NZs exhibit differences in tonic block, peak whole-cell I Na was measured during a depolarizing pulse to Ϫ25 mV after a 10-s period at Ϫ90 mV in the absence of drug and in 3 concentrations of lidocaine. The density of drug-free I Na in IZs (5.5Ϯ0.53 pA/pF, nϭ38, V H ϭϪ100 mV) was significantly reduced compared with that of NZs (14.4Ϯ0.66 pA/pF, nϭ50, PϽ0.01) similar to our previous report. 6 Furthermore, the reduction of I Na due to lidocaine (120 mol/L) was significantly greater in IZs than in NZs (V H ϭϪ90 mV) (Table 1) (PϽ0.05). Even at lower lidocaine concentrations, there was a consistent trend suggesting greater sensitivity of I Na in IZs. Nevertheless, in the absence as well as presence of lidocaine, I Na in IZs was significantly reduced compared with that of NZs.
When tonic block was assessed at more hyperpolarizing prepulses (Ϫ110 mV versus Ϫ90 or Ϫ100 mV, Table 1 ), differences in tonic lidocaine action on IZs and NZs were minimized. We have previously shown that the voltage dependence of steady-state availability is shifted in the hyperpolarizing direction for I Na in IZs. 6 To determine whether differences in steady-state inactivation might explain these voltage-dependent differences in I Na block in IZs and NZs, we examined the availability of I Na over a wide range of inactivating membrane potentials (Figure 1 ). Under drug-free conditions, the fitted V 0.5 of IZs was Ϫ83.3Ϯ0.77 mV, negative to that of NZs (Ϫ79.2Ϯ0.5 mV). Lidocaine (120 mol/L) produced a greater negative shift in V 0.5 in IZs than in NZs (Ϫ11.9Ϯ0.82 versus Ϫ9.05Ϯ0.59 mV, Pϭ0.01, Figure 1A ). At lower drug concentrations, a similar trend suggesting a greater negative shift in IZs was observed but did not reach statistical significance ( Figure 1B) . The time course of loss of availability of I Na was obtained using a double-pulse protocol, where I Na was induced from V H of Ϫ100 to Ϫ25 mV after a conditioning pulses to Ϫ60 mV with varied duration. Each I Na was normalized to maximal I Na (conditioning pulse, 0 ms), plotted against conditioning prepulse duration. The time course of loss of I Na availability was then described by biexponential function. Panels A and B illustrate the effects of lidocaine (120 mol/L) on percent I Na remaining unavailable, with a prepulse of varying duration to The negative shift in the voltage dependence of drug-free steady-state availability for IZs may explain why the tonic block difference between IZs and NZs is more prominent at a holding potential of Ϫ90 mV than at Ϫ110 mV. In the drug-free condition, I Na in NZs at Ϫ90 mV are 88.6Ϯ1.2% available (I/I max ), whereas that of IZs is only 78Ϯ3.5% available ( Figure 1A) , suggesting a larger fraction of I Na in IZs is inactivated at Ϫ90 mV. Conversely, at Ϫ110 mV, both IZs and NZs are fully reprimed in the absence of lidocaine. Lidocaine binds more avidly to the inactivated state(s) of the cardiac Na ϩ channel than to noninactivated, rested states. 32, 33 Hence, IZs held at Ϫ90 mV exhibit greater tonic block of I Na than do NZs, whereas at more hyperpolarized potentials where the degree of inactivation for both IZs and NZs is minimized, tonic block of I Na is not significantly different.
Effects of Lidocaine on Time-Dependent Loss of Availability in NZs and IZs
We have previously reported accelerated development of inactivation from a preopen, closed state in IZs versus NZs in drug-free conditions. 6 Recent studies of lidocaine action in inactivation-disabled mutants suggest that lidocaine not only binds with high affinity to inactivated channels 15 but also may accelerate the rate of inactivation. 16 Therefore, we examined whether inactivation gating changes in IZs (Figure 2 ) influence lidocaine-induced changes in a time-dependent loss of availability. Loss of availability from closed states was examined using a conditioning pulse to Ϫ60 mV of varying duration. Lidocaine accelerated the rate at which channels became unavailable to open in both NZs and IZs ( Figure 2B) . We used the percentage of unavailable channels after a 200-ms prepulse to Ϫ60 mV as a model-independent index to compare the rate of loss of availability for both cell types in the absence and presence of lidocaine. In drug-free conditions, by 200 ms at Ϫ60 mV, 83.9Ϯ2.8% of channels were inactivated in IZs compared with only 66.5Ϯ2.9% in NZs (PϽ0.01), indicating that inactivation from closed states was accelerated in IZs relative to NZs. 6 In lidocaine (120 mol/L), 80.8Ϯ3.1% were unavailable for opening in NZs, and the degree of availability was only slightly greater in IZs (90.5Ϯ2.8%, PϭNS) ( Figure 2B ). Lidocaine accelerated the rate at which channels became unavailable from preopen states in both cell types. Percent change in unavailability at 200 ms induced by lidocaine (20, 60 , and 120 mol/L) in NZs (18Ϯ2%, 15Ϯ3%, and 20Ϯ2%) and IZs (8Ϯ2%, 6Ϯ1%, and 8Ϯ2%) were dissimilar and not dose dependent. Nevertheless, with drug exposure the difference between NZs and IZs was minimized.
In drug-free conditions, development of inactivation in both cell types has been described by a biexponential func- tion. 6 We therefore fit biexponential functions to the data as a qualitative means to examine the effects of lidocaine on these kinetic components, recognizing that 2 exponentials underestimate the total number of kinetic transitions during closed-state inactivation under these conditions. In both cell types, lidocaine produced a decrease in both the fast and slow time constants ( 1 and 2 , respectively) and also decreased the relative amplitude of the fast time constant (A 1 ) ( Table 2 ). The net effect of drug in the different subset of cells of both cell types was an accelerated loss of availability. The effects of lidocaine on 1 , 2 , and A 1 were dose dependent (Pϭ0.015, Pϭ0.34, and Pϭ0.026, respectively) in NZs over a 20-to 120-mol/L range, whereas in IZs dose-dependent effects of lidocaine did not reach statistical significance ( Table 2 ). The lidocaine-induced reduction in 2 and A 1 was significantly greater in NZs than IZs at 120 mol/L (PϽ0.05), consistent with the qualitative effect of lidocaine to minimize the difference between the 2 cell groups.
Use-Dependent Effects of Lidocaine on IZs and NZs
We have reported that I Na in IZs exhibits a delay in recovery from inactivation relative to NZs. 6 In drug-free conditions, such a delay in recovery should be manifested as a difference in the rate at which I Na diminishes during rapid trains of depolarizing pulses (use dependence). Under drug-free conditions, we examined use-dependent reduction of I Na in IZs and NZs at 3 stimulation frequencies. Repetitive clamp steps (40-ms duration) from a V H of Ϫ100 mV produced a frequency-dependent reduction of peak current in both cell types, but the effects in IZs were significantly greater, particularly at rapid pacing rates (2 and 3 Hz) ( Figure 3A) . Consistent with the slowed rate of Na ϩ channel recovery from inactivation at depolarized membrane potentials in drug-free conditions (see below), the IZϪNZ differences in usedependent reduction of I Na at 3 Hz were exaggerated at more depolarized recovery potentials (V H , Figure 3B) .
Lidocaine increased the use-dependent reduction of I Na in a dose-dependent manner in both NZs and IZs (3 Hz). As in the drug-free condition, IZs exhibited significantly greater usedependent reduction of I Na compared with NZs with the lowest lidocaine concentration (20 mol/L) (circles, Figure 4) . However, at the higher concentrations (60 and 120 mol/L), differences between NZs and IZs were eliminated. Under drugfree conditions, I Na is reduced (pulse 20/pulse 1) by 10.7Ϯ1.5% in IZs but only by 6.2Ϯ0.9% in NZs (3 Hz, V H ϭϪ100 mV, PϽ0.01 versus NZs). Conversely, in 60 mol/L lidocaine (squares, Figure 4) , there was no difference between NZs and IZs (50.9Ϯ4.5% in IZs and 47.3Ϯ3.2% in NZs, PϭNS). Similar results were obtained in 120 mol/L lidocaine (62.3Ϯ2.5% in IZs and 59.9Ϯ2.3% in NZs, PϭNS) (inverted triangles, Figure 4) .
Under drug-exposed conditions in which NZs and IZs exhibit similar degrees of use-dependent I Na reduction, similar rates of recovery of availability should also be apparent. . Frequency-dependent and V H -dependent reduction of I Na in drug-free conditions. A, I Na was elicited by repetitive clamp steps from V H at Ϫ100 to Ϫ25 mV for 40 ms in drug-free conditions at 1-, 2-, and 3-Hz pacing rates. The average beat-to-beat reduction of I Na (I/I 1st ) during the 20-pulse train is shown. Frequency-dependent reduction of I Na was seen in both NZs (solid symbols) and IZs (open symbols). However, the reduction at the 20th beat in IZs was significantly greater than that in NZs at 2 Hz (squares) and 3 Hz (triangles) (see P values). B, I Na was elicited by repetitive clamp steps from V H at Ϫ90, Ϫ100, and Ϫ110 mV to Ϫ25 mV for 40 ms in drug-free conditions at 3 Hz. I/I 1st during the pulse train for each cell group at the different V H is shown. The reduction of I Na was V H dependent in both cell types; however, I Na reduction was significantly greater in IZs (see P values). Figure 4 . Use-dependent block of I Na by lidocaine (lido) at different concentrations in NZs and IZs. For these data, I Na was elicited in separate subsets of cells from V H at Ϫ100 mV to Ϫ25 mV for 40 ms at 3 Hz before and after lido. Each subset of cells had its own control. I Na for each beat was normalized to I Na of the first beat (I/I first ) in presence of drug concentration indicated. The degree of lido use-dependent block of I Na was dependent on pacing rate, V H , and drug concentration. At each drug concentration, this fast pacing rate produced more block in both cell groups. However, at 20 mol/L lido, IZs showed a greater use-dependent block compared with NZs. P values are for comparison between NZs and IZs. Figure 5 examines recovery of availability as a function of time at -100 mV after a 1000-ms conditioning pulse to Ϫ25 mV. As shown previously, 6 in the absence of drug a delay in recovery from inactivation occurs in IZs compared with NZs. As a model-independent means of comparing the rate recovery of availability in the absence and presence of drug, we measured fractional recovery of availability by 100 ms at -100 mV. Fractional recovery by IpI at 100 ms was 76.1Ϯ2.5% for NZs but only 63.7Ϯ2.8% for IZs (PϽ0.01) under drug-free conditions ( Figure 5B ). Drug exposure substantially increased the delay in recovery for both cell types; in lidocaine (20, 60 , and 120 mol/L), the respective percent change induced by IpI at 100 ms was 37Ϯ2%, 61Ϯ4%, and 77Ϯ0.8% for NZs and 44Ϯ3%, 61Ϯ3%, and 77Ϯ2% for IZs (PϽ0.001 for both cell groups). Consistent with the usedependent results, lidocaine minimized the difference in the rate of recovery of availability for the 2 cell types ( Figure 5) .
To assess the effect of lidocaine on fast and slow components of recovery of availability, we fit the recovery data to a biexponential expression ( 1 and 2 ). A delay (d) was incorporated to account for a third exponential component seen in the early recovery phase of drug-free IZs and both NZs and IZs exposed to lidocaine (see Materials and Methods). Lidocaine increased both time constants of recovery, the delay, and the amplitude of the slow (A 2 ) component in both cell types (Table 3) . Furthermore, the differential effects of lidocaine on the individual kinetic components reported in Table 3 were consistent with the overall action to reduce predrug differences in recovery of excitability.
Discussion Experimental Considerations
The experimental conditions were highly unphysiological, yet they were chosen for the following reasons: Voltage-clamp control of the cell membrane was considered. Under physiological conditions, I Na is large, and the kinetics are so rapid that successful voltage-clamp control is challenging, even in single-cell preparations. 34, 35 Some investigators have been successful with a macropatch technique. 36, 37 For these reasons, the usual way to study I Na in the whole-cell recording configuration is to reduce experimental temperature and lower the Na ϩ gradient. 30,34,38 -40 Under our conditions, I Na in 91% of NZs was reduced to Ͻ3 nA, with the largest I Na being 4.16 nA. These values are similar to other reported values under similar conditions. 30 Although a time-dependent negative shift of the steadystate availability curve has been described during whole-cell I Na recordings, we think it is unlikely that this phenomenon has influenced our results. First, we found time-dependent changes to be similar in cells of the 2 groups, and currents of the 2 groups were measured at similar times after membrane rupture. 6 Second, as we have discussed previously, 4, 5 it is unlikely that the current reduction and alteration of Na ϩ channel kinetics are due to the surgical procedure, cell isolation process, or criteria used for cell selection. 4, 5 A contamination of outward currents present only in IZs cannot account for the I Na reduction, since the composition of intracellular and extracellular solutions was chosen to minimize contaminating currents. An increase of the cell capacitance or membrane surface area without change in the absolute channel number and a negative shift of I/I max curve can only be responsible for a portion of the current reduction measured, since the total amplitude of I Na was also reduced in IZs versus NZs, and the maximally available I Na in drug-free conditions remained significantly different in IZs versus NZs.
Lidocaine Minimizes Gating Differences Between IZs and NZs
We have previously shown that IZs and NZs exhibit marked differences in inactivation gating. Recent studies have shown that mutations and subunit interactions that modify Na ϩ channel gating can in turn influence lidocaine action.
15-18,41 Therefore, we tested the hypothesis that the Na ϩ channel gating changes induced in cells that survive in the infarcted heart also influence the effects of lidocaine on the whole-cell I Na .
Although I Na density in IZs was significantly lower than in NZs, we found no statistical relationship between I Na density and the degree of tonic block (data not shown). Nonetheless, tonic block by lidocaine is significantly increased in IZs when the resting membrane potential is partly depolarized, and differences were attenuated when the membrane was hyperpolarized. These effects are readily explained by differences in the voltage dependence of drug-free steady-state inactivation relations for IZs and NZs (Figure 1 ). Since the voltage dependence of IZs is shifted negative to that of NZs, a larger proportion of Na ϩ channels in IZs is inactivated at relatively depolarized V H s. Recent studies examining the greater tonic block effects of lidocaine in cardiac versus skeletal muscle Na ϩ channels have proposed an identical mechanism based on the negative shift in the voltage dependence of steady-state inactivation in the cardiac isoform. 42 Similarly, developmental changes in Na ϩ channel blocking properties of lidocaine in the postnatal rat heart have been attributed to changes in inactivation gating. 43 The negative shift in the drug-free steady-state availability curve in IZs relative to NZs suggests that one or more inactivated states are energetically stable in IZs. Consistent with this, the drug-free rate of development of inactivation from closed states is accelerated in IZs (Figure 2) , and the drug-free rate of recovery from inactivation is delayed (Figure 5) , causing a significant enhancement of drug-free usedependent reduction of I Na in IZs relative to NZs. In both cell types, lidocaine accelerated the rate at which channels became unavailable to open (Figure 2) , delayed the recovery of availability ( Figure 5) , and enhanced the use-dependent reduction of I Na during rapid trains of stimuli in a dosedependent manner (Figure 4 ). Most notably, differences in the rates of loss and recovery of availability in the 2 cell types were eliminated with higher concentrations of lidocaine. Functional manifestation of this effect is best illustrated in Figure 4 , where lidocaine eliminated the drug-free differences between IZs and NZs in the use-dependent reduction of I Na .
Many features of use-dependent drug action are explained by the modulated receptor model, which suggests that lidocaine affinity for the Na ϩ channel is highest in the inactivated conformational state. However, recent studies using mutant Lidocaine produced an increase in the fast recovery time constant 1 , which was accompanied by decreasing the relative amplitude of the 1 component (A 1 ) and increasing the 2 component (A 2 ) dose-dependently in both cell types. This effect was greater in NZs than in IZs at 120 mol/L. Lidocaine also increased 2 in NZs but not in IZs; this difference reached significance at 60 and 120 mol/L. Data used to construct these relationships were obtained at similar times after membrane rupture (at 20 mol/L, 28Ϯ1.1 and 51Ϯ1.6 minutes for NZs and 30Ϯ1.3 and 55Ϯ2.9 minutes for IZs; at 60 mol/L, 28Ϯ0.9 and 55Ϯ1.8 minutes for NZs and 31Ϯ0.8 and 53Ϯ2.3 minutes for IZs; and at 120 mol/L, 27Ϯ0.8 and 48Ϯ2.1 minutes for NZs and 27Ϯ0.9 and 49Ϯ1.1 minutes for IZs). % Increase refers to change in values. P value indicates the comparison of % increase in 1 channels with modified inactivation properties indicate that lidocaine not only binds with highest affinity to the inactivated state but can also accelerate the inactivation process, suggesting that local anesthetic drugs may function under more general paradigms applicable to allosteric effector molecules. 16 Lidocaine could be shifting the inactivation gating equilibrium in a manner that favors occupancy of slow-inactivated states, which may not differ for NZs and IZs. Support for this model derives from accumulating evidence that site-directed mutations 44 or ␣-␤ 1 subunit interactions 41 directed toward shifting the inactivation gating equilibrium away from slow inactivation are effective in attenuating use-dependent lidocaine action.
At this time, we cannot exclude the possibility that usedependent effects of lidocaine are somehow related to a drug interaction with fast inactivation in both cell types. First, it is possible that differences between IZs and NZs are blunted in lidocaine because of a marked drug-induced change in fast inactivation gating kinetics that somehow masks the distinctive gating properties seen in rapid, drug-free gating conditions. The nonlinear behavior of multistate Na ϩ channel gating models with a number of additional drug-associated kinetic states may predict such behavior. Alternatively, it is possible that Na ϩ channels in IZs are less "sensitive" to lidocaine and that the drug may therefore accelerate I Na inactivation and slow its recovery from inactivation more in NZs than in IZs. Finally, given the effects of the ␤ 1 subunit in heterologous expression systems on lidocaine-induced use dependence, 18, 45 fast-and slow-inactivation gating, and channel density, 46 -50 the influence of myocardial infarction on Na ϩ channel density, gating, and lidocaine action in myocytes surviving in the border zone may be partly related to primary effects of the disease on the status of the Na ϩ channel ␤ 1 subunit. Our results motivate future studies to examine the role of structural elements, such as subsidiary subunits, in Na ϩ channel gating and antiarrhythmic drug action in cells that survive in the infarcted heart.
